Cargando…
Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer
BACKGROUND: Estrogenic signals are suggested to have protection roles in the development of colorectal cancer (CRC). The G protein-coupled estrogen receptor (GPER) has been reported to mediate non-genomic effects of estrogen in hormone related cancers except CRC. Its expression and functions in CRC...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418684/ https://www.ncbi.nlm.nih.gov/pubmed/28476123 http://dx.doi.org/10.1186/s12943-017-0654-3 |
_version_ | 1783234088377778176 |
---|---|
author | Liu, Qiao Chen, Zhuojia Jiang, Guanmin Zhou, Yan Yang, Xiangling Huang, Hongbin Liu, Huanliang Du, Jun Wang, Hongsheng |
author_facet | Liu, Qiao Chen, Zhuojia Jiang, Guanmin Zhou, Yan Yang, Xiangling Huang, Hongbin Liu, Huanliang Du, Jun Wang, Hongsheng |
author_sort | Liu, Qiao |
collection | PubMed |
description | BACKGROUND: Estrogenic signals are suggested to have protection roles in the development of colorectal cancer (CRC). The G protein-coupled estrogen receptor (GPER) has been reported to mediate non-genomic effects of estrogen in hormone related cancers except CRC. Its expression and functions in CRC were investigated. METHODS: The expression of GPER and its associations with clinicopathological features were examined. The mechanisms were further investigated using cells, mouse xenograft models, and clinical human samples. RESULTS: GPER was significantly (p < 0.01) down regulated in CRC tissues compared with their matched adjacent normal tissues in our two cohorts and three independent investigations from Oncomine database. Patients whose tumors expressing less (n = 36) GPER showed significant (p < 0.01) poorer survival rate as compared with those with greater levels of GPER (n = 54). Promoter methylation and histone H3 deacetylation were involved in the down regulation of GPER in CRC cell lines and clinical tissues. Activation of GPER by its specific agonist G-1 inhibited proliferation, induced cell cycle arrest, mitochondrial-related apoptosis and endoplasmic reticulum (ER) stress of CRC cells. The upregulation of reactive oxygen species (ROS) induced sustained ERK1/2 activation participated in G-1 induced cell growth arrest. Further, G-1 can inhibit the phosphorylation, nuclear localization, and transcriptional activities of NF-κB via both canonical IKKα/ IκBα pathways and phosphorylation of GSK-3β. Xenograft model based on HCT-116 cells confirmed that G-1 can suppress the in vivo progression of CRC. CONCLUSIONS: Epigenetic down regulation of GPER acts as a tumor suppressor in colorectal cancer and its specific activation might be a potential approach for CRC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-017-0654-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5418684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54186842017-05-08 Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer Liu, Qiao Chen, Zhuojia Jiang, Guanmin Zhou, Yan Yang, Xiangling Huang, Hongbin Liu, Huanliang Du, Jun Wang, Hongsheng Mol Cancer Research BACKGROUND: Estrogenic signals are suggested to have protection roles in the development of colorectal cancer (CRC). The G protein-coupled estrogen receptor (GPER) has been reported to mediate non-genomic effects of estrogen in hormone related cancers except CRC. Its expression and functions in CRC were investigated. METHODS: The expression of GPER and its associations with clinicopathological features were examined. The mechanisms were further investigated using cells, mouse xenograft models, and clinical human samples. RESULTS: GPER was significantly (p < 0.01) down regulated in CRC tissues compared with their matched adjacent normal tissues in our two cohorts and three independent investigations from Oncomine database. Patients whose tumors expressing less (n = 36) GPER showed significant (p < 0.01) poorer survival rate as compared with those with greater levels of GPER (n = 54). Promoter methylation and histone H3 deacetylation were involved in the down regulation of GPER in CRC cell lines and clinical tissues. Activation of GPER by its specific agonist G-1 inhibited proliferation, induced cell cycle arrest, mitochondrial-related apoptosis and endoplasmic reticulum (ER) stress of CRC cells. The upregulation of reactive oxygen species (ROS) induced sustained ERK1/2 activation participated in G-1 induced cell growth arrest. Further, G-1 can inhibit the phosphorylation, nuclear localization, and transcriptional activities of NF-κB via both canonical IKKα/ IκBα pathways and phosphorylation of GSK-3β. Xenograft model based on HCT-116 cells confirmed that G-1 can suppress the in vivo progression of CRC. CONCLUSIONS: Epigenetic down regulation of GPER acts as a tumor suppressor in colorectal cancer and its specific activation might be a potential approach for CRC treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-017-0654-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-05 /pmc/articles/PMC5418684/ /pubmed/28476123 http://dx.doi.org/10.1186/s12943-017-0654-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Liu, Qiao Chen, Zhuojia Jiang, Guanmin Zhou, Yan Yang, Xiangling Huang, Hongbin Liu, Huanliang Du, Jun Wang, Hongsheng Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer |
title | Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer |
title_full | Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer |
title_fullStr | Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer |
title_full_unstemmed | Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer |
title_short | Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer |
title_sort | epigenetic down regulation of g protein-coupled estrogen receptor (gper) functions as a tumor suppressor in colorectal cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418684/ https://www.ncbi.nlm.nih.gov/pubmed/28476123 http://dx.doi.org/10.1186/s12943-017-0654-3 |
work_keys_str_mv | AT liuqiao epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer AT chenzhuojia epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer AT jiangguanmin epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer AT zhouyan epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer AT yangxiangling epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer AT huanghongbin epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer AT liuhuanliang epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer AT dujun epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer AT wanghongsheng epigeneticdownregulationofgproteincoupledestrogenreceptorgperfunctionsasatumorsuppressorincolorectalcancer |